low molecular weight heparin

(redirected from Fraxiparin)

low mo·lec·u·lar weight hep·a·rin

(LMWH) (lō mŏ-lek'yŭ-lăr wāt hep'ăr-in)

A form of heparin with a longer half life and fewer adverse effects (e.g., thrombocytopenia).

Medical Dictionary for the Health Professions and Nursing © Farlex 2012

low molecular weight heparin

Abbreviation: LMWH

The most bioavailable fraction of heparin. It has a more precise anticoagulant effect than unfractionated heparins and is used to prevent and treat deep venous thrombosis, pulmonary embolism, and acute coronary syndromes.

CAUTION!

It should be used selectively, if at all, in patients with reduced kidney function.

See also: heparin

References in periodicals archive ?

Fraxiparin and one dose of antibiotics (Cephalosporin 1-2 g) were

NOVEL DIAGNOSTIC AND THERAPEUTIC APPROACHES TO THE TREATMENT OF OVARIAN CANCER/SAVREMENI DIJAGNOSTICKO-TERAPIJSKI PRISTUP U LECENJU KARCINOMA JAJNIKA

Examples of LMWHs include Lovenox, Fragmin, Sandoparin, Innohep, and Fraxiparin.

Too thin for comfort: a red-blooded medical challenge: creating a safer treatment to counteract the effect of blood thinners

Fraxiparin enmascarado, 936 HNF: 5.000 Study Group paralelo q8h (47) Kakkar y Doble 199 NC: 3.075 q.d.